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Abstract
Lifestyle emerging diseases like obesity, metabolic syndrome (MeS), and diabe-
tes mellitus are considered high-risk factors for lethal arrhythmias and side effects. 
A Poincaré plot is constructed with the time series of RR and PP electrocardiogram 
(ECG) intervals, using two stages: the new phase and the old phase. We proposed 
this diagram of two dimensions, a way to quantify and observe the regularity of 
events in space and time. Therefore, the heart rate variability (HRV) can be used as 
a biomarker for early prognostic and diagnostic of several metabolic diseases; addi-
tionally, this biomarker is obtained by a noninvasive tool like the electrocardiogram.
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1. Introduction
The biological phenomena could be explained by classical physics, and most of 
these phenomena are characterized by cycles. Usually, the time period required to 
“complete a cycle” is not constant. The study of time period fluctuations represents 
a way to assess interactions between other systems and the intrinsic properties of 
the same system.
The light/dark cycle (circadian rhythm) and the cyclic seasons that divide the 
year by changes on weather, ecology, and hour of daylight allowed the evolution 
of life on earth [1]. These series of events have influenced the organisms inducing 
cycles that are essential for life (hormonal, organ function, behavior, production 
of neurotransmitters, reproduction, and others); all cycles are fluctuations related 
to several biological phenomena. The study and knowledge of the fluctuations of 
biological phenomena are valuable to analyze the intrinsic properties of a system 
and the interaction with other cyclic systems [2].
The quantification of biological variability has been used to study several 
physiological phenomena, among them, fluctuations on the heart rate using the RR 
interval period of the electrocardiogram (ECG). The heart rate variability (HRV) is 
a useful health indicator [3], and in this chapter we detail how this tool is used for 
the prognosis and diagnosis of metabolic diseases.
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2. Biological variability
All organisms present dynamic and complex oscillations in their function. The 
time between every oscillation is called period, and it represents biological rhythms. 
These rhythms regulate all physiological processes with periods of milliseconds 
as neuronal activity, seconds as the heart rate, hours as hormone release, monthly 
as the ovarian cycle, and annually as the growth and migration. The biological 
rhythms are present in all levels of biological organization at the molecular, organ-
elle, cell, and tissue levels; these organizations are present in vertebrates, inverte-
brates, and plants (Figure 1).
The study of period variations is essential because these fluctuations represent 
the interaction of the cycles with other systems or alterations on the intrinsic 
properties of the same system, individual and interspecific variability [4].
The periods can oscillate only under the influence of an external periodic signal 
originating exogenous rhythms; these allow changes in the variability of biological 
rhythm associated with external environmental synchronizer [5]. However, when 
the light/darkness external synchronizer is removed, a self-sustaining oscillation is 
shown, so it is said that the system has an autonomous endogenous rhythm.
The biological rhythms with a periodicity of 24 h are denominated circadian 
rhythms (circa = about, diem = a day). These circadian rhythms develop an endogen 
rhythm with one period close to 24 h under constant darkness, the free running, but 
can be synchronized again with the light and darkness; this phenomenon is called 
circadian entrainment. The circadian rhythms of longer period are infradians, 
such as the menstrual cycle, while shorter periods are ultradians, such as cardiac 
frequency, the autonomic system regulation, electrical activity of neurons, and 
secretion of hormones, among others (see Figure 1).
Figure 1. 
Variability biologic system. All organisms develop the variability of biological systems for environmental 
adaptation. Physiological and metabolic processes depend on the interaction between the central and peripheral 
rhythms.
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The autonomous nervous system (sympathetic and parasympathetic) 
regulates the cardiovascular system that involves the heart rate variability. The 
relevance that the intermittent oscillations of peripheral clocks modulate the 
variability of the central clock is fundamental for health process. The coordina-
tion and communication among peripheral and central clock are essential for 
metabolic, enzymatic, molecular, and physiological process.
3. Heart rate
The heart rate (HR) is determined by the activity of the sinoatrial node. The 
electrical activity propagates to the atria and then to the atrioventricular node, and, 
finally, the electrical activity reaches the ventricles triggering its contraction from 
apex to base. Any change in the origin and propagation of this electrical activity 
is denominated arrhythmia. The contraction and relaxation of cardiac tissue is a 
process named heartbeat. It is a cyclical event, the beats per minute produce the 
heart rate. Heart rate is a parameter that serves to diagnose some health problems 
in patients. When HR is increased, it is called tachycardia and the decrease of HR is 
called bradycardia. Tachycardia is related to exercise, emotions, the fight or flight 
phenomenon, among other activities. Bradycardia is related to sleep and rest. To 
measure HR there are several methods that are used in the clinic, like pulse taking, 
auscultation, and electrocardiography.
4. Heart rate variability
The interaction of the organisms with its environment causes changes in the 
metabolic requirements of the multiple tissues that are depending on the circulating 
blood to supply oxygen and nutrients and remove metabolic waste, i.e., age, physi-
cal conditioning or exercise, behavior (emotions, pathologies, spice that is being 
studied, activity that takes place when the HR is taken, hemorrhages, heart attacks, 
addictions). In response to these demands, the heart adapts its interbeat intervals.
These intervals vary thanks to the intrinsic properties of the heart (spontaneous 
activity of the sinoatrial node [6] and atrial and ventricular electrical properties 
along with extracellular matrix composition) and especially the influence of the 
autonomic nervous system (ANS), a communication pathway between the heart 
and the whole body. This system modulates the spontaneous activity of the sino-
atrial node and conduction system of the heart (Figure 2).
The ANS regulates heart rate, visceral activities, and glandular functions to 
keep homeostasis. The ANS innervation on the heart can be divided in sympathetic 
(SNS) and parasympathetic (PNS) nervous system. They both have opposing 
effects on the heart activity. The sympathetic nervous system is responsible for the 
“fight or run” response, increasing the myocardium contractile properties and the 
rate of spontaneous activity of the sinoatrial node (SAN), the natural pacemaker 
of the heart, augmenting the heart rate. On the other hand, the parasympathetic 
nervous system has an inhibitory effect on the peacemaker and atrioventricular 
node (NAV) activity (see Figure 2), adjusting to rest states by means of a decrease 
in the heart rate [2].
Sympathetic innervation secretes norepinephrine, a neurotransmitter that links 
to β1 receptors on the cardiac sarcolemma activating G proteins. This union induces 
a conformational change that dissociates the αs subunit activating adenylyl cyclase. 
The activated adenylyl cyclase catalyzes the conversion of ATP to AMPc, which joins 
directly to ionic channels responsible for the hyperpolarization activated pacemaker 
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current (If) increasing the SAN depolarization rate. This stimulus also increases 
the opening probability and the inward calcium current enhancing the strength 
of cardiac contraction. Parasympathetic innervation releases acetylcholine, a 
neurotransmitter that binds to M2 receptors on the cardiac sarcolemma activating 
inhibitory G proteins, inducing a conformational change in Gi protein that dissoci-
ates the αi subunit inhibiting adenylyl cyclase leading to a decrease in the formation 
of AMPc, thus decreasing the SAN depolarization rate. The dynamical interaction 
between SNS and PNS enables the heart to fulfill the organism requirements in the 
short and long term.
Since the heartbeat is a cyclic phenomenon that repeats continually as a result of 
the interaction between spontaneous SAN activity [7], passive and active properties 
of the myocardium, conduction system, and ANS influence, it can be regarded as 
a result of the interaction of multiple coupled systems that oscillate. This complex 
nonlinear interaction reflects on interbeat interval variability; such phenomenon is 
called heart rate variability.
The interbeat intervals are usually assessed as the time between the R-wave 
peaks of the ECG signal (RR time series). This registry is consequence of the spatial 
and temporal sum of the electrical activity of the whole heart, and each wave is 
characteristic of specific electrical events. The R wave is representative of the QRS 
complex, which is the result of the ventricular transmural depolarization heteroge-
neity [8]. In view on the fact that the time from the start of the depolarizing wave 
at the sinoatrial node to the ventricle depolarization can account as other oscillation 
sources, inter-beat interval indicated by the PP interval (depolarization of the atria) 
can provide some insights that can be concealed by the RR interval (Figure 2).
HRV analysis is a valuable noninvasive method to quantify modifications caused 
by aging, disease progression, and other physiologic or pathologic changes. These 
alterations influence the oscillating systems or the way they couple, as sympathetic 
and parasympathetic heartbeat modulation besides intrinsic properties of the heart 
Figure 2. 
Heart rate variability sources. The time interval variations between consecutive heartbeats are result of the 
interaction between the autonomous nervous system modulation and intrinsic properties of the heart regulating 
its function.
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that rely on extracellular matrix, sarcolemma composition (ionic channel density 
and kinetics, gap junction density, lipid composition), myocyte size, adipocyte, and 




To analyze HRV using the ECG signal, we used the R waves of the QRS complex. 
The evaluation of the time between an R-wave peak (R1) and the next immediate 
R-wave peak (R2), the time interval between the appearance of an R wave and the 
next (t1–2) will be called heart period. The RR intervals are organized in chrono-
logical order, with an organized set of numbers. This set will be called the “heart 
activity time series.”
The heart rate (number of beats per unit of time) can be estimated as the inverse 
of the time period. When the frequency is stable, it is always the same, so are the 
period and the time series. When the time series is plotted against its order appear-
ance, a time series graph is obtained [10]. The times series values determine the 
shape of the graph. When the frequency is constant, the graph is a parallel line to 
the time axis. And in the case that the frequency has variations (HRV), the graph is 
like in Figure 3.
The time series has all the information of the variability of system; then, to 
determine that two time series are similar, numerical values were allocated to this 
variability. The first tool used was RR time series spectral analysis, this technique 
is based on the use of all periodic signals consisting of sums of sine and cosine 
functions with different frequencies and amplitudes, with the purpose to deter-
mine which frequencies are involved in the formation of the time series [10]. The 
frequencies obtained by this mathematical tool have been associated to the nervous 
system, breathing, and other physiological functions. The frequencies and power 
spectrum of the different components of the time series are the parameters used to 
quantify the variability with this method [11].
The disadvantage (if it can be considered as one) of using this method is that not 
everybody is expert in Fourier series; therefore it’s difficult to analyze, interpret, 
and perform. The second tool we use is the Poincaré plots. They require graphing 
Figure 3. 
Heart rate variability analysis. (A) Time series with chronological order and (B) Poincaré plot of time series.
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the time series as follows: the first RR1 interval is assigned as x value, and then the 
value of the RR2 interval is assigned as y; this ordered pair is plotted on a Cartesian 
coordinate axis. Now we consider RR2 as x, and RR3 as y to plot it. After that the rest 
of the RR intervals are graphed in the same way, where the x is the RR(i) interval 
and the y is the interval RR(i+1); we plot each RR interval against the next immedi-
ate one. The resulting graphs are converted into spot stains; this chart is known as 
Poincaré plot (Figure 3). Now the question is how to quantify the spots. Before we 
give an answer to the problem, we will first describe the advantages of Poincaré 
plot.
5.2 Advantages of the Poincaré plots
First of all, it is important to mention that the heart rate will be 1/RRi; conse-
quently the analysis of the interval variations gives us information of the heart rate 
variation. That is, the Poincaré plots give us information about changes in heart rate 
even if this parameter is not explicitly represented in this graph. As above men-
tioned, the frequency (F) is the inverse of the time period (T), hence F*T = 1.
In the plot we trace the identity straight line RR(i+1) = RR(i), this line divides the 
plane into three parts: one where the RR(i+1) is equal to RR(i) (blue line in Figure 3), 
another where RR(i+1) > RR(i) which is the top of the identity line. And the third 
where RR(i+1) < RR(i) which is the part that is under the identity line (Figure 3). 
Therefore, just by looking at the point localization, we can say that the next interval 
has a higher value, i.e., the frequency is less. In other words, when the points fall 
above the identity straight line, the period i + 1 is greater and the further the point is 
from the identity line, the value of the period i + 1 will be greater; otherwise when 
the points are under the identity graph, the period i + 1 will be smaller, and the 
frequency will be higher [3].
5.3 SDD1 and SDD2 calculation
The distance between the points and the identity straight line tells us what 
the instantaneous (or sequential) changes of the RR interval will look like, as 
mentioned in the short term [12]. As an example, we will mention that when the 
distance from the points to the identity straight line is zero RR(i+1) = RR(i), there 
are no changes in the interval, but if this distance becomes greater, the variation 
between RR is greater. These distances are called D1i; the D1i distances that are above 
the identity straight line will be positive and those below will be negative in such 
a way that the average of these distances are zero, but the standard deviation of 
these distances (SDD1) will be different from zero, and this parameter will be used 
to characterize the width of the Poincaré plot. The width or SDD1 will be used to 
determine the variability of D1; this parameter is related to the short-term variabil-
ity of the RR, and this relates to the interaction of the sympathetic system and the 
heart. To calculate SDD1 all distances from points to the identity line are calculated 
the average and standard deviation [3, 13]. Thus it is found that
  D1i =  √ 
____________
  (  RR i −  RR i+1  _2 ) 
2
  (1)
All D1i distances are added and divided by the number of distances to get the 
average; the standard deviation to the latter is called SDD1. SDD1 is a parameter that 
characterizes short-term variability.
Secondly, calculate the distance from all points to the perpendicular line that 
crosses the identity line at the coordinate point of the mean value (RRm, RRm). This 
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distance is called D2j (Eq. (2) and Figure 3). All D2j distances are added and divided 
by the number of distances to get the average; the standard deviation to the latter is 
called SDD2.
The RR variability changes can be obtained based on the RR time series without 
using explicitly the time:
  D2j =  √ 
_____________________
  2  ( 2 ¯  RR j −  RR j  −  RR j+1  _________________2 ) 
2
 (2)
where  ¯  RR j is the average value of the sum of all RR intervals.
By obtaining the values of SDD1 and SDD2, we quantify the variability of the 
heart rate in the short and long term. This data defines the coefficient of variability 
as SDD1/SDD2.
Using the Poincaré plots, the quantification of the variability in the heart rate is 
determined by calculating SDD1, SDD2, and the SDD1/SDD2 ratio. The advantage of 
this method is that the calculation of these parameters is clearly arithmetic, and just 
by looking at the Poincaré, plot you have an idea of how the variability is given.
6. Biomarkers
A biological marker or biomarker is any substance, structure, or process that is 
objectively measured and evaluated as an indicator of normal biological processes. 
The biomarkers in the medical science field play essential role for disease detection, 
pathogenic responses, and therapeutic intervention. These markers are obser-
vational side products with potential utility in clinical and research studies [14]. 
Additionally they are used in new treatment strategies for clinical management. The 
biomarker field opens the opportunity to originate new knowledge in the complex 
health scheme.
7. Metabolic disease
Metabolic alterations cause metabolic diseases as result of changes in chemical 
reactions in the organism by several enzyme deficit, developing alterations like lipid 
metabolism disorders. These diseases are associated with synthesis and degrada-
tion of fatty acids. The principal and general symptoms of metabolism injury are 
lethargy, weight alteration, inflammatory process, seizures, and jaundice.
8. Metabolic syndrome
For the last decade, the cardiovascular diseases have been the first cause of death 
worldwide, and the deadly arrhythmias have increased in the industrialized coun-
tries; this fact is related to lifestyle and metabolic alterations such as sedentarism 
and diet [15, 16]. Obesity and metabolic syndrome are disorders associated with 
metabolic modifications.
The metabolic syndrome has been described as a cluster of several signs 
like abdominal obesity, hyperglycemia, dyslipidemia, and high blood pressure 
(Figure 4). These factors predispose to develop cardiovascular diseases, and each 
component is strongly correlated with CVD. An opportune diagnosis is necessary to 
know the progression of MeS and predisposition to develop lethal risks. HRV analy-
sis is a tool to assess cardiac function in patients with several pathologic conditions. 
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However, relationships between HRV and cardiac rhythm with changes in MeS have 
not been found, improving considerably the prognostic and diagnostic of MeS, as 
well as the side effects.
The ECG is a biomarker for early diagnosis of metabolic diseases [3], and to asses 
HRV, a five random minute interval must be measured and analyzed. When more 
time is analyzed, the characteristic SDD1 and SDD2 will be lost [3]. In humans, the 
MeS showed changes in RR intervals; SDD1 or short-term variability was modified 
in young adults, while in woman and elderly human, the alterations were vagal as 
sympathovagal balance (SDD1 and SDD2 [17]).
Also, spectral analysis with Fourier transform was used for the 24-h ECG record; 
this analysis showed that in human, the high frequencies (HF 0.15–0.40 Hz), which 
represents sympathetic modulation, were lower only in women with metabolic syn-
drome [18] and at low frequencies (LF 0.04–0.15 Hz), which represent parasym-
pathetic modulation, heart rate was not altered by MeS. Furthermore, individual 
components of the MeS were highly correlated with imbalance cardiac autonomic 
system; the obesity modifies sympathetic nervous system [19]; hyperglycemia alters 
parasympathetic system [20]; and microalbuminuria, dyslipidemia, and hyperten-
sion do not alter neither of them but decrease LF/HF index (see Figure 4) [21, 22].
Rats with obesity and hypertension presented similar cardiovascular changes 
as humans: a decrease in parasympathetic system without any increase in sympa-
thetic modulation [23], and only temporary alterations in sympathetic nervous 
system were reported in rats with high sucrose diet, insulin resistance, and 
visceral fat (epididymal fat) [24]. However, the rats with high sucrose diet showed 
higher LF than control [25], and also the heart rate was decreased showing sinus 
bradycardia and a threefold increase of heart rate variability, SDD1 15 ± 0.4, and 
SDD2 69 ± 1, compared with control animals 5.5 ± 0.1 and 26 ± 0.1, respectively. 
In addition, sinoatrial node doubled its variability as shown in the SDD1/SDD2 
index = 0.25 for control condition and MeS: SDD1/SDD2 = 0.55 [26]. In genetically 
modified rats, cardiac alterations were observed independently on individual 
characteristic of MeS (see Figure 4).
Figure 4. 
The metabolic syndrome increases the heart rate variability. (A) The cluster signs of MeS increase the risk to 
develop cardiovascular diseases (CVD) and diabetes mellitus. (B) ECG of control and MeS rats, showing lower 
heart rate in MeS rats. (C) Poincaré plots exhibiting lower balance between parasympathetic and sympathetic 
systems. (D) Fourier analysis indicating that lower frequencies predominate in MeS rat RR time series.
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9. Diabetes mellitus
The cardiac arrhythmias in diabetes mellitus are due to structural and func-
tional remodeling, which are alterations in the architecture of the heart that 
include fibrosis, fat deposition, hypertrophy, modification in the utilization, and 
production of energy. In addition, electrical activity remodeling includes failure in 
electrical conduction, dysregulation in ion channels and gap junctions [27], and all 
these changes are added to the autonomic imbalance between the sympathetic and 
parasympathetic nervous systems until it becomes cardiac autonomic neuropathy 
(CAN), which is recognized as a risk for development of atrial fibrillation and sud-
den cardiac death (see Figure 5)[28].
In order to realize clinical diagnosis of CAN, the performing cardiac autonomic 
reflex test or neuropathy Ewing’s battery is recommended. It consists of the assess-
ment of the HRV in rest condition, while standing, during paced deep breathing, 
during sustained muscle contraction with the use of a handgrip dynamometer 
(handgrip exercise), and during and after a provoked increase in intrathoracic/
abdominal pressure (maneuver of Valsalva) (see Figure 5) [29, 30].
Unfortunately, these tests have limitations: patients must be aware so they can 
perform each of the tests, and it is necessary to suspend medications that could alter 
the results of the test (e.g., the avoidance of medications that cause hypotension, 
such as diuretics, tricyclic antidepressants, and vasodilators) [31].
Due to these disadvantages, the measurement of HRV has been used as an 
alternative for CAN diagnosis in recent years because it is a noninvasive test, it 
does not provoke pain in the patient, the analysis is performed in a short time, it 
is reliable, and it is a low-cost technique. In addition, this methodology allows the 
HRV analysis to be performed in less time because it is not necessary to have spe-
cialized knowledge in statistics or mathematics since the values of SDD1, SDD2, 
and SDD1/SDD2 are obtained by means of relatively simple arithmetic calculations 
and it does not need specialized software to perform them [3]. Another improve-
ment is that the Poincaré plot analysis can be done with only 100 RR intervals, 
which excludes the use of a Holter registry without reducing the reliability and 
sensitivity of the test [32].
Several authors have reported a decrease in HRV in patients with DM types 
1 and 2 regardless of the method used to measure it (frequency-domain HRV 
or time domain). The decrease in HRV in diabetic patients is associated with an 
early phase of the evolution of CAN. There is a loss of parasympathetic function 
with a relative increase of sympathetic function causing an imbalance of the 
sympathetic/parasympathetic tone (without parasympathetic denervation). The 
patient experiments an increase in resting heart rate. In the next stage, sympa-
thetic denervation takes place increasing the risk of arrhythmias [33]. Despite 
the existence of a large number of studies on HRV in diabetic patients, we still do 
not have a relationship that allows us to know the stage of damage in which the 
autonomic nervous system is found.
On the other hand, we have validated the use of HRV and the measurement of 
SDD1, SDD2, and the Poincaré SDD1/SDD2 index (Eqs. (1) and (2)) as a biomarker 
for diagnosis and prognosis of cardiac autonomic neuropathy. For this purpose, a 
model of type 1 diabetes pharmacologically induced by STZ was used. This model 
was developed in CD1 mice in which the progress of disease is allowed for 10 weeks 
without insulin administration (the time compared with human 8 years of disease 
progression), which produces a decrease in the values of SDD1 (1 vs. 0.9), SDD2 (1.3 
vs. 0.8), and SDD1/SDD2 (0.8 vs. 1.1) compared to the control (Figure 6) [32].
In this stage of the disease, no decrease in heart rate was reported, which sug-
gests that CAN was in the early stages. However, after a time period equivalent to 
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15 human years of DM induction without hypoglycemic treatment CAN, a decrease 
in HRV is developed (Figure 6). Additionally, in this second stage, mice showed 
denervation in the pacemaker tissue [13]. We conclude that the use of HRV and 
Poincaré plots could detect CAN even in early stages of the disease, and therefore 
it will allow introducing therapeutic maneuvers to control the symptoms and delay 
the damage to the ANS due to DM.
Figure 6. 
Poincaré plots of interval RR of ECG. The HRV in conditions of control vs. 8 years of DM development. The 
influence of the ANS allowed maintaining the balance of an elliptical shape.
Figure 5. 
Relations between alterations in DM and cardiac arrhythmias. The alterations in the architecture of heart 
tissue and functions produce a decrease in HRV during diabetes, which increment the risk of arrhythmias.
11
Heart Rate Variability as Biomarker for Prognostic of Metabolic Disease
DOI: http://dx.doi.org/10.5772/intechopen.88766
10. Conclusions
The periodic oscillations in biological phenomena are quantified with the 
purpose to use them as a health indicator (biomarker) in mammalian. By means of 
the ECG interval analysis, HRV is quantified using RR and PP time series. Poincaré 
plots were constructed, and three indicators were obtained: SDD1, SDD2, and SDD1/
SDD2 index. The behavior of these indicators is related with health or metabolic 
disease. In MeS, a sympathovagal imbalance was reported, and the parasympathetic 
system showed alterations with a twofold increase in SDD2 indicator. Furthermore, 
the three indicators were decreased by DM. These biomarkers have the advantages 
of being based on a noninvasive tool, being objective, and being obtained by easy 
arithmetic calculus. In addition, the shape of the Poincaré plots offers qualitative 
information by only looking at it.
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